GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » JRSIS Health Care Corp (OTCPK:JRSS) » Definitions » Debt-to-EBITDA

JRSIS Health Care (JRSIS Health Care) Debt-to-EBITDA : 0.73 (As of Dec. 2023)


View and export this data going back to 2015. Start your Free Trial

What is JRSIS Health Care Debt-to-EBITDA?

Debt-to-EBITDA measures a company's ability to pay off its debt.

JRSIS Health Care's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Dec. 2023 was $1.01 Mil. JRSIS Health Care's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Dec. 2023 was $0.03 Mil. JRSIS Health Care's annualized EBITDA for the quarter that ended in Dec. 2023 was $1.41 Mil. JRSIS Health Care's annualized Debt-to-EBITDA for the quarter that ended in Dec. 2023 was 0.73.

A high Debt-to-EBITDA ratio generally means that a company may spend more time to paying off its debt. According to Joel Tillinghast's BIG MONEY THINKS SMALL: Biases, Blind Spots, and Smarter Investing, a ratio of Debt-to-EBITDA exceeding four is usually considered scary unless tangible assets cover the debt.

The historical rank and industry rank for JRSIS Health Care's Debt-to-EBITDA or its related term are showing as below:

JRSS' s Debt-to-EBITDA Range Over the Past 10 Years
Min: -31.79   Med: 2.88   Max: 35.52
Current: 35.52

During the past 11 years, the highest Debt-to-EBITDA Ratio of JRSIS Health Care was 35.52. The lowest was -31.79. And the median was 2.88.

JRSS's Debt-to-EBITDA is ranked worse than
98.13% of 427 companies
in the Healthcare Providers & Services industry
Industry Median: 2.58 vs JRSS: 35.52

JRSIS Health Care Debt-to-EBITDA Historical Data

The historical data trend for JRSIS Health Care's Debt-to-EBITDA can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

JRSIS Health Care Debt-to-EBITDA Chart

JRSIS Health Care Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Debt-to-EBITDA
Get a 7-Day Free Trial Premium Member Only Premium Member Only 3.96 2.05 -31.79 -2.91 35.52

JRSIS Health Care Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Debt-to-EBITDA Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -1.43 -0.03 -0.03 -0.02 0.73

Competitive Comparison of JRSIS Health Care's Debt-to-EBITDA

For the Medical Care Facilities subindustry, JRSIS Health Care's Debt-to-EBITDA, along with its competitors' market caps and Debt-to-EBITDA data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


JRSIS Health Care's Debt-to-EBITDA Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, JRSIS Health Care's Debt-to-EBITDA distribution charts can be found below:

* The bar in red indicates where JRSIS Health Care's Debt-to-EBITDA falls into.



JRSIS Health Care Debt-to-EBITDA Calculation

Debt-to-EBITDA measures a company's ability to pay off its debt.

JRSIS Health Care's Debt-to-EBITDA for the fiscal year that ended in Dec. 2023 is calculated as

Debt-to-EBITDA=Total Debt / EBITDA
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / EBITDA
=(1.005 + 0.025) / 0.029
=35.52

JRSIS Health Care's annualized Debt-to-EBITDA for the quarter that ended in Dec. 2023 is calculated as

Debt-to-EBITDA=Total Debt / EBITDA
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / EBITDA
=(1.005 + 0.025) / 1.412
=0.73

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual Debt-to-EBITDA, the EBITDA of the last fiscal year is used. In calculating the annualized quarterly data, the EBITDA data used here is four times the quarterly (Dec. 2023) EBITDA data.


JRSIS Health Care  (OTCPK:JRSS) Debt-to-EBITDA Explanation

In the calculation of Debt-to-EBITDA, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by EBITDA. In some calculations, Total Liabilities is used to for calculation.


Be Aware

A high Debt-to-EBITDA ratio generally means that a company may spend more time to paying off its debt.

According to Joel Tillinghast's BIG MONEY THINKS SMALL: Biases, Blind Spots, and Smarter Investing, a ratio of Debt-to-EBITDA exceeding four is usually considered scary unless tangible assets cover the debt.


JRSIS Health Care Debt-to-EBITDA Related Terms

Thank you for viewing the detailed overview of JRSIS Health Care's Debt-to-EBITDA provided by GuruFocus.com. Please click on the following links to see related term pages.


JRSIS Health Care (JRSIS Health Care) Business Description

Traded in Other Exchanges
N/A
Address
No. 19 Chang Yi Road, 3rd Floor, Building A, De Run Yuan, Chang Ming Shui, Wu Gui Shan, Zhongshan, CHN, 528458
JRSIS Health Care Corp is engaged in operating Jiarun Hospital, a private hospital with nearly 950 open beds. The Jiarun Hospital services in the areas of pediatrics, dermatology, ears, nose, and throat (ent), traditional Chinese medicine (TCM), ophthalmology, internal medicine dentistry, general surgery, rehabilitation science, gynecology, general medical services, and others. It also offers patient care and the sale of medicine in the areas of both Western and Chinese medical practices to the residents of Harbin.
Executives
Zhuowei Zhong director, 10 percent owner, officer: President 5 JUMEI BIG STREET, XIAOLAN TOWN, ZHONGSHAN CITY, GUANGDONG PROVINCE F4 528415
Zhifei Huang director, officer: Chief Executive Officer 3 FIVE ALLEY, DITANGKOU, PINGWANGGANGXIE, DATANG TOWN, SANSHUI DISTRICT, FOSHAN, GUANGDONG PROVINCE F4 528143
Zhuowen Chen director, officer: Chief Financial Officer 401 BUILDING 23, JIANGPAN NEW RESIDENTIAL QUARTERS, ZHONGSHAN CITY, GUANGDONG PROV F4 528401
Lihua Sun director, officer: Chief Executive Officer 1ST-7TH FLOOR,IND & COMM BANK BLDG,, XINGFU ST, HULAN TOWN, HULAN DISTRICT, HARBIN F4 150599
Junsheng Zhang director, 10 percent owner, officer: President and Chm of the Board 1ST-7TH FLOOR,IND & COMM BANK BLDG,, XINGFU ST, HULAN TOWN, HULAN DISTRICT, HARBIN F4 150599
Xuewei Zhang director, officer: Chief Financial Officer 1ST-7TH FL, IND & COMM BANK BLDG., XINGFU ST, HULAN TOWN, HULAN DISTRICT, HARBIN F4 150599
Yanhui Xing director A204, BLOCK 1, ZHUJIANG XUJING GARDEN, BANXUEGANG RD, LONGGANG DISTRICT, SHENZHEN F4 518000

JRSIS Health Care (JRSIS Health Care) Headlines